EP2168475B1 - Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique - Google Patents

Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique Download PDF

Info

Publication number
EP2168475B1
EP2168475B1 EP08016828A EP08016828A EP2168475B1 EP 2168475 B1 EP2168475 B1 EP 2168475B1 EP 08016828 A EP08016828 A EP 08016828A EP 08016828 A EP08016828 A EP 08016828A EP 2168475 B1 EP2168475 B1 EP 2168475B1
Authority
EP
European Patent Office
Prior art keywords
receiver
transmitter
optical
fibre
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP08016828A
Other languages
German (de)
English (en)
Other versions
EP2168475A1 (fr
Inventor
Jürg Fröhlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luciole Medical AG
Original Assignee
Nemodevices AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemodevices AG filed Critical Nemodevices AG
Priority to EP08016828A priority Critical patent/EP2168475B1/fr
Priority to AT08016828T priority patent/ATE547980T1/de
Priority to US13/119,325 priority patent/US8909313B2/en
Priority to PCT/EP2009/006410 priority patent/WO2010034398A1/fr
Publication of EP2168475A1 publication Critical patent/EP2168475A1/fr
Application granted granted Critical
Publication of EP2168475B1 publication Critical patent/EP2168475B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683—Means for maintaining contact with the body
    • A61B5/6832—Means for maintaining contact with the body using adhesives
    • A61B5/6833—Adhesive patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552—Details of sensors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means

Definitions

  • the present invention relates to a device for diagnosis and/or therapy of a selected portion of a body by optical reflectance or optical transmission, according to the preamble of claim 1.
  • NIRS near infrared spectroscopy
  • An assembly of the device includes a base support pad having two socket holes in which module sockets can be installed. These module sockets are formed with an open base end and provide housings for so called optical modules.
  • Each optical module includes an optical fibre cable made up of a bundle of optical fibres which couples through quick disconnect optical coupling, leading directly to a light source and a processing circuitry.
  • the optical fibres terminate with a right angle shaped terminal end destined for deflecting an optical light signal at least approximately of an angle of 90°.
  • the terminal end has a slightly protruding portion with respect to the open base end of the module socket, establishing a ground optical face.
  • the terminal end of the fibre bundles can provide both, a near-infrared light source terminal destined for bringing light to the point of light entry of the selected portion of the body, or a near-infrared light detector terminal being destined for collecting and transmitting reflected/transmitted light for further processing and calculations.
  • the optical modules can be fully nested in their respective module sockets. Therefore, the module sockets include an open slot for receiving the optical fibre cable of the optical module which leads to the light source and the processing circuitry.
  • the base support pad is formed with two parallel slits leading from the socket holes to an edge of the base support pad. These slits are intended, amongst others, for facilitating the assembling of the base support pad and the module sockets together with their respective optical modules.
  • each of the module sockets is provided at the open base end with three radially extending, thin, and flexible tabs. A double sided adhesive tape is attached on each tab as a means for affixing the respective module socket on the base support pad.
  • a further embodiment of a device for measuring cerebral hemodynamics and oxygenation invasively is disclosed in EP 1 301 119 . It uses passive illuminating and receiving means, i.e. at least two optical transmission means, each comprising one or more optical fibres.
  • a first transmission means transmits light from its proximal to its distal end, i.e. from a light source to a patients head and brain tissue.
  • a second transmission means transmits light from its distal to its proximal end, i.e. from the patient's head and brain tissue to a detection unit.
  • the transmission means are encapsulated by a coating forming an elongated, flat structure which fixes the spatial arrangement of the transmission means.
  • each transmission means is connected to a deflection means encapsulated by the same coating, being at least in a region of entrance respectively exit of the deflection means optically transmissive to light at wavelengths used.
  • the deflection means are destined for deflecting light transmitted by the transmission means from a direction of transmission, preferably by an angle of 60 to 120°. Preferably the light is deflected by approximately 90° with respect to the direction of transmission. Since optical fibres are small in diameter and deflecting means can be manufactured small in size, the device destined for minimal invasive measurements can be assembled with a width of preferably less than about 20 mm and a thickness of preferably less than about 5 mm.
  • Document WO 94/12096 discloses a patient sensor for optical cerebral oximeters.
  • An optical sensor for use in spectrophotometric patient-examination apparatus having a body of softly deformable material so as to be conformable to the patient, with an internally mounted electro-optical source and receivers for obtaining patient data by transmission of selected wavelengths through a tissue volume adjacent the sensor, including substantially non-deforming light transfer members disposed in alignment with the source and detector and between them and the patient to provide substantially constant and unchanging light transfer passages or conduits there between.
  • the light transfer members comprise generally tubular elements having light reflective inner walls
  • the sensor body comprises either a layered structure of opaque, soft polymeric foam or the like (cellular urethane) or a substantially one-piece molded or other such structure of generally analogous characteristics.
  • the device according to the present invention may be used for any non-invasive and invasive method for diagnosis and/or therapy of a selected portion of a body by optical reflectance or optical transmission, preferably using light in the near infrared region of 700 nm to 1300 nm spectral domain.
  • the device has a laminar body, exhibiting a tissue-facing surface and an exterior surface averted from said tissue-facing surface.
  • the laminar body integrally forms a transmitter cavity and a receiver cavity.
  • the transmitter cavity has a transmitter housing portion and a transmitter passage portion
  • the receiver cavity has a receiver housing portion and a receiver passage portion.
  • the transmitter passage portion is discharging into the transmitter housing portion, accordingly, the receiver passage portion is discharging into the receiver housing portion.
  • the transmitter housing portion of the transmitter cavity is destined to accommodate a transmitter fibre terminal containing an optical transmitter fibre
  • the receiver housing portion of the receiver cavity is destined to accommodate a receiver fibre terminal containing an optical receiver fibre.
  • the transmitter passage portion allows passing there through the optical transmitter fibre
  • the receiver passage portion allows passing there through the optical receiver fibre.
  • the transmitter fibre terminal is designed for directing light incoming through the transmitter fibre towards a direction at least approximately perpendicular to the tissue-facing surface of the laminar body.
  • the receiver fibre terminal is designed for collecting incoming light from and at least approximately perpendicular to the tissue contacting surface 68 in the optical receiver fibre 16a, 16b.
  • annular transmitter light shielding bulge and an annular receiver light shielding bulge are formed and firmly arranged with respect to the laminar body. They are destined for shielding ambient light from the transmitter fibre terminal and the receiver fibre terminal, respectively.
  • free ends of the light shielding bulges are protruding with respect to the tissue-facing surface of the laminar body.
  • the laminar body integrally forms the transmitter cavity with the transmitter housing portion and the receiver cavity with the receiver housing portion which accommodate the fibre transmitter terminal and the fibre receiver terminal, respectively, the laminar body can be manufactured small in size, with a width probably less than about 15 mm and a thickness less than about 10 mm.
  • the fibre transmitter and the fibre receiver terminals as e.g. reflective optical terminals according to claim 5 and 6. These reflective optical terminals further support a fabrication of the whole device which is small in size.
  • All single parts of the device may be assembled before an actual measurement, allowing to sterilize and to prepackage the whole device, completely assembled, e.g. as a single use kit, without the need of assembling single components by an end user before using the device.
  • an optical connector which can be connected, eventually by an optical cable, with an apparatus including light emitting and evaluation means may further simplify a setup procedure
  • annular transmitter light shielding bulge and the annular light receiver shielding bulge are firmly arranged with respect to the laminar body and may be integrally formed by a transmitter sleeve and a receiver sleeve, respectively, according to claim 4.
  • the end user does not have to take care about light shielding issues e.g. by mounting adhesive light shielding tapes.
  • the reflective optical transmitter terminal has a transmitter terminal tissue contacting surface and the reflective optical receiver terminal has a receiver terminal tissue contacting surface, both lying on the site and being at least approximately in parallel to the tissue-facing surface of the laminar body. They are destined for getting in contact with the selected portion of the body. Furthermore, as specified in claims 6 to 8, the reflective optical transmitter terminal and the reflective optical receiver terminal can be flexibly supported within their respective housings. Thereby, a spring force may act on said reflective optical transmitter terminal and on said reflective optical receiver terminal in a direction at least approximately perpendicular to said tissue-facing surface.
  • the spring force may effect that the transmitter terminal tissue contacting surface and the receiver terminal tissue contacting surface are slightly protruding or at least are approximately on a same plane with respect to the free ends of the transmitter and receiver light shielding bulges. Therewith, the transmitter terminal tissue contacting surface and the receiver terminal contacting surface are slightly pressed during application against the selected portion of the body providing optimal light emitting and light detecting conditions.
  • Fig. 1 and fig. 2 show a device 10 adapted for non invasive measurements of hemodynamics and oxygenation of a brain by optical reflectance.
  • the device includes a laminar body 12 in the shape of a band, preferably made of a plastic material, having a tissue-facing surface 13 and an exterior surface 14 averted from the tissue-facing surface 13.
  • the device 10, i.e. an optical transmitter fibre 15 and a first and a second optical receiver fibre 16a, 16b, are connected on one end with an optical connector 17 which is firmly arranged with respect to said laminar body 12.
  • the optical connector 17 interacts as interface between the device 10 and an apparatus for NIRS measurements including light emitting, light detecting, and evaluation means, as e.g. disclosed in EP 1 301 119 . Thereby, the optical connector 17 is connected to the apparatus for NIRS measurements either directly or by an optical cable.
  • the laminar body 12 integrally forms a transmitter cavity 18, located in the free end region of the laminar body 12, opposite to the site on which the optical connector 17 is located.
  • the transmitter cavity 18 has a transmitter housing portion 20 and a transmitter passage portion 22. Said transmitter passage portion 22 is discharging into said transmitter housing portion 20.
  • the transmitter housing portion 20 is destined to accommodate a transmitter fibre terminal 24 including the optical transmitter fibre 15.
  • the transmitter passage portion 22 allows passing there through the optical transmitter fibre 15, leading through the laminar body 12 from the transmitter housing portion 20 to optical connector 17.
  • the laminar body 12 integrally forms one or more receiver cavities.
  • a first receiver cavity 28a and a second receiver cavity 28b are formed.
  • the first receiver cavity 28a is located between the optical connector 17 and the transmitter cavity 18, a distance "a" of at least approximately 4.5 cm away from the transmitter cavity 18.
  • the second receiver cavity 28b is located between the first receiver cavity 28a and the transmitter cavity 18, a distance "b" of at least approximately 1.5 cm away from the transmitter cavity 18.
  • Said distances are adapted for measurements of an adult normal sized brain. For measurements on smaller sized heads, as e.g. heads of newborns, heads with thicker cranial bones or cranial bones with higher bone densities, the distances have to be adapted accordingly.
  • the first receiver cavity 28a has a first receiver housing portion 30a and a first receiver passage portion 34a
  • the second receiver cavity 28b has a second receiver housing portion 30b and a second receiver passage portion 34b.
  • Said first and second receiver passage portions 34a, 34b are discharging into said first and second receiver housing portions 30a, 30b, respectively.
  • the first and second receiver housing portions 30a, 30b are destined to accommodate a first receiver fibre terminal 38a and a second receiver fibre terminal 38b, including the first and the second optical receiver fibres 16a, 16b, respectively.
  • the first and the second receiver passage portions 34a, 34b allow passing there through the first and the second optical receiver fibres 16a, 16b, respectively, leading through the laminar body 12 from the respective first and second receiver housing portion 30a, 30b to the optical connector 17.
  • the laminar body 12 exhibits - in the top view - button shaped protrusions in regions of the transmitter cavity 18 and the first and second receiver cavities 28a, 28b. Furthermore, the thickness of the laminar body 12 with respect to the tissue-facing surface 13 is augmented in said regions in order to form said transmitter cavity 18 and said first and second receiver cavities 28a, 28b.
  • the transmitter housing portion 20 and the first and the second receiver housing portions 30a, 30b are formed as a blind-hole. Furthermore, said transmitter housing portion 20 and said first and second receiver housing portions 30a, 30b are open towards the tissue-facing surface 13 of said laminar body 12.
  • the laminar body 12 is flexible in directions at least approximately perpendicular to the tissue-facing surface 13, allowing a certain adoption of its shape corresponding to a shape of a selected portion of a body, as e.g. to an outer surface of a cranial bone. In directions parallel to the tissue-facing surface 13, the laminar body 12 should exhibit a certain stiffness in order to maintain the spatial arrangement between the transmitter cavity 18 and the first and the second receiver cavities 28a, 28b, i.e. to fix the distance "a" and the distance "b".
  • the laminar body 12 is preferably composed of a material with light shielding properties in order to assist in providing the desired light shielding around the transmitter fibre terminal 24 and the receiver fibre terminals 38a, 38b.
  • annular transmitter light shielding bulge 46 and a first and a second annular receiver light shielding bulge 48a, 48b are formed, respectively, firmly arranged with respect to said laminar body 12.
  • said annular transmitter light shielding bulge 46 and said first and second annular receiver light shielding bulges 48a, 48b are slightly protruding or are at least approximately on a same plane with respect to said laminar body 12.
  • a transmitter sleeve 50 and a first and a second receiver sleeve 52a, 52b are arranged within said transmitter housing portion 20 and said first and second receiver housing portions 30a, 30b, respectively. They are firmly affixed with respect to the laminar body 12.
  • said transmitter sleeve 50 is extending over at least approximately the entire depth of said transmitter housing portion 20 in a direction at least approximately perpendicular to said tissue-facing surface 13, having a transmitter sleeve through passage portion 54 which allows passing there through the optical transmitter fibre 15.
  • said first and second receiver sleeves 52a, 52b preferably are extending over at least approximately the entire depth of said first and second receiver housing portions 30a, 30b, respectively, in a direction at least approximately perpendicular to said tissue-facing surface 13.
  • the first and second receiver sleeves 52a, 52b have a first and a second receiver sleeve through passage portion 56a, 56b, respectively, which allow passing there through the first and second optical receiver fibres 16a, 16b, respectively.
  • the transmitter sleeve 50 and the first and second receiver sleeves 52a, 52b fulfill preferably light shielding functions by shielding the transmitter fibre terminal 24 and the first and second receiver fibre terminals 38a, 38b from ambient light sources.
  • Said transmitter sleeve 50 and said first and second receiver sleeves 52a, 52b are composed of a resilient, preferably opaque, material, as e.g. black-coloured foam. Furthermore, the annular transmitter light shielding bulge 46 and the first and second annular receiver light shielding bulges 48a, 48b are integrally formed by said transmitter sleeve 50 and said first and second receiver sleeves 52a, 52b, respectively.
  • the laminar body 12 is preferably covered by a foam layer 58, preferably with light absorbing properties, firmly arranged on the tissue-facing surface 13 of the laminar body 12.
  • the foam layer 58 has a laminar body contacting surface 59 facing towards the tissue-facing surface 13 of said laminar body 12 and a foam layer tissue-facing surface 60 averted from said laminar body contacting surface 59.
  • the foam layer 58 is destined for providing additional light shielding.
  • the annular transmitter light shielding bulge 46 and the first and second annular receiver light shielding bulges 48a, 48b are slightly protruding or are at least approximately on a same plane with respect to said foam layer tissue-facing surface 60.
  • an adhesive patch 62a, 62b, laterally protruding with respect to the laminar body 12 is also firmly arranged on the exterior surface 14 of the laminar body 12 in order to affix the device 10 on the selected portion of the body.
  • the transmitter fibre terminal 24 and the first and second receiver fibre terminals 38a, 38b are constructed as a reflective optical transmitter terminal 64 and a first and a second reflective optical receiver terminal 66a, 66b, respectively.
  • the reflective optical transmitter terminal 64 has a transmitter terminal tissue contacting surface 68, preferably planar shaped, and the first and second reflective optical receiver terminals 66a, 66b have a preferably planar shaped first and second receiver terminal tissue contacting surface 70a, 70b, respectively.
  • Preferred embodiments of said reflective optical transmitter and receiver terminals 64, 66a, 66b are depicted and described in more details in fig. 6 - fig. 9 .
  • the reflective optical transmitter terminal 64 and the first and second reflective optical receiver terminals 66a, 66b can be flexibly supported within the transmitter housing portion 20 of the transmitter cavity 18 and the first and second receiver housing portions 30a, 30b of the first and second receiver cavities 28a, 28b, respectively.
  • a spring force caused by a helical pressure spring 72a, 72b, 72c acting on said reflective optical transmitter terminal 64 and on said first and second reflective optical receiver terminal 66a, 66b in a direction at least approximately perpendicular to the tissue-facing surface 13 of the laminar body 12 effects that the transmitter terminal tissue contacting surface 68 and the first and second receiver terminal tissue contacting surfaces 70a, 70b are slightly protruding or at least are approximately on a same plane with respect to the free ends of the annular transmitter light shielding bulge 46 and of the free ends of the first and the second annular receiver light shielding bulges 48a, 48b.
  • the transmitter terminal tissue contacting surface 68 and the first and second receiver terminal tissue contacting surfaces 70a, 70b are slightly pressed against the selected portion of the body, providing optimal light emitting and light detecting conditions, respectively.
  • a first optical signal collected within the first optical receiver fibre 16a originates from light which was emitted into the tissue at the point of the transmitter terminal tissue contacting surface 68 and then was reflected by scalp, cranial bone, cerebrospinal fluid, and brain tissue.
  • a second optical signal collected within the second optical receiver fibre 16b originates from light which was emitted into the tissue at the point of the transmitter terminal tissue contacting surface 68 and then was reflected by at least approximately only the scalp and the cranial bone. From said first and second collected optical signal, a wanted signal originating at least almost only from cerebrospinal fluid and brain tissue can be derived by appropriate calculations.
  • Fig. 3 and fig. 4 show a different embodiment of a device 76 suitable for example for measurements of hemodynamics and oxygenation of finger tissue 78 by optical transmission.
  • the device 76 is assembled with the same elements as the device 10 in figure 1 and fig. 2 , but, in contrast to the device 10 in fig. 1 and fig. 2 , the device 76 does not contain the second receiver cavity 28b and all respectively assigned elements.
  • the transmitter cavity 18, the transmitter housing portion 20, the transmitter fibre terminal 24 as well as the first receiver cavity 28a, the first receiver housing portion 30a, and the first receiver fibre terminal 38a are equally formed as the respective elements in the device 10.
  • the laminar body 12 of the device 76 exhibits a T-shaped form, integrally formed by a T-crossbar portion 79 and a T-stringer portion 80, both, the T-crossbar portion 79 and the T-stringer portion 80 having the shape of a band.
  • the optical connector 17 is firmly affixed with respect to the laminar body 12.
  • the transmitter cavity 18 is arranged on one free end region of the T-crossbar portion 79, whereas the first receiver cavity 28a is arranged on an opposite free end region of the T-crossbar portion 79.
  • the optical transmitter fibre 15, the transmitter passage portion 22 allowing passing there through the optical transmitter fibre 15, the first optical receiver fibre 16a, and the first receiver passage portion 34a allowing passing there through the first optical receiver fibre 16a exhibit also a different line management compared to the embodiment in the device 10 of fig. 1 and fig. 2 .
  • the device 76 they are leading through the T-crossbar portion 79 and the T-stringer portion 80 within the laminar body 12, from the transmitter housing portion 20 and the first receiver housing portion 30a, respectively, to the optical connector 17.
  • a velcro strip 81 protruding on each side of the T-crossbar portion 79 of the laminar body 12 can be used.
  • the distance between the transmitter cavity 18 and the first receiver cavity 28a has to be chosen in such a way that the transmitter cavity 18 is located at least almost directly on the opposite site of the selected portion of the body during the measurement, with respect to the location of the transmitter cavity.
  • the distance between the transmitter cavity 18 and the first receiver cavity 28a in a flat, unmounted state of the laminar body 12 is at least approximately 1.5 cm, depending on the size of the respective figer.
  • Fig. 5 shows a zoomed part of fig.
  • fig. 5 illustrates a possible, non invasive external arrangement of the device 10 on a scalp 82.
  • the transmitter cavity 18 as well as the first and the second receiver cavities 28a, 28b with all respective assigned elements are equally mounted and fixated on the scalp as illustrated exemplarily in fig. 5 with the first or the second receiver cavity 28a, 28b.
  • the laminar body is flexibly formed in order to adopt its shape to the shape of the scalp, i.e. the cranial bone, and the distance between the transmitter cavity 18 and the first and second receiver cavities 28a, 28b is fixed.
  • the first optical receiver fibre terminal 38a light reflected by the scalp 82, cranial bone 83, cerebrospinal fluid 84, and brain tissue 86 of a patient is received
  • the second optical receiver fibre terminal 38b light reflected at least almost only by the scalp 82 and the cranial bone 83 is received.
  • Fig. 6 and fig. 7 show a preferred embodiment of the reflective optical transmitter terminal 64 in a bottom view and in a cross section, respectively.
  • the reflective optical transmitter terminal 64 is constructed by a circular cylindrical body 88a, preferably composed of a light-transmissive material. It contains on one side the circular transmitter terminal tissue contacting surface 68, which is preferably planar shaped. On the side opposite of and in parallel to said circular transmitter terminal tissue contacting surface 68, the circular cylindrical body contains a preferably planar shaped spring force anchorage surface 90a which provides a contact surface for the helical pressure spring.
  • the main axis 92a of the circular cylindrical body 88a is perpendicular to said circular transmitter terminal tissue contacting surface 68.
  • An end portion of the reflective optical transmitter fibre 15 is enclosed by the circular cylindrical body 88a, whereas the entry point 94a of the optical transmitter fibre 15 into the circular cylindrical body 88a is located at least approximately in the middle of the cylinder barrel.
  • the optical transmitter fibre 15 enters in a radial direction, perpendicular to the main axis 92a of the circular cylindrical body 88a, into the circular cylindrical body 88a, running preferably at least almost to the centre of the circular cylindrical body 88a.
  • the circular cylindrical body 88a On the side opposite to said entry point 94a, the circular cylindrical body 88a exhibits a notch 96a defining two planar surfaces, one planar surface 97a in parallel to the transmitter terminal tissue contacting surface 68, the other surface being bevelled 98 with respect to the transmitter terminal tissue contacting surface 68.
  • the bevelled surface 98 is destined for deflecting incoming light from the optical transmitter fibre 15 in a direction at least approximately perpendicular to and towards the transmitter terminal tissue contacting surface 68. Therefore, it exhibits optical light deflection means, preferably a mirror 100.
  • Fig. 8 and fig. 9 show an embodiment of the first and second reflective optical receiver terminals 66a, 66b in a bottom view and in a cross section, respectively.
  • the reflective optical receiver terminal 66a, 66b is constructed by a further circular cylindrical body 88b, preferably composed of a light-transmissive material. It contains on one side the spherical receiver terminal tissue contacting surface 70a, 70b, which is preferably planar shaped. On the side opposite of and in parallel to said circular receiver terminal tissue contacting surface 70a, 70b, the circular cylindrical body 88b contains a further preferably planar shaped spring force anchorage surface 90b which provides a contact surface for the helical pressure spring.
  • the main axis 92b of the circular cylindrical body is perpendicular to said circular receiver terminal tissue contacting surface 70a, 70b.
  • An end portion of the reflective optical receiver fibre 16a, 16b is enclosed by the circular cylindrical body 88b, whereas the entry point 94b of the optical receiver fibre 16a, 16b into the circular cylindrical body 88b is located at least approximately in the middle of the cylinder barrel.
  • the optical receiver fibre 16a, 16b enters in a radial direction, perpendicular to the main axis 92b of the circular cylindrical body 88b, into the circular cylindrical body 88b, running preferably at least almost to the centre of the circular cylindrical body 88b.
  • the circular cylindrical body 88b On the side opposite to said entry point 94b, the circular cylindrical body 88b exhibits a further notch 96b defining two further surfaces, one further surface 97b which is planar shaped and in parallel to the receiver terminal tissue contacting surface 70a, 70b, the other exhibiting a concave shaped surface 102.
  • the concave shaped surface 102 preferably acting as a parabolic light reflector, is destined for collecting incoming light from and at least approximately perpendicular to the receiver terminal tissue contacting surface 70a, 70b in the optical receiver fibre 16a, 16b. Thereby, the end portion of the optical receiver fibre is situated at least almost in the focal point of the parabolic light reflector.
  • the concave shaped surface optical light deflection means preferably a concave mirror 104.
  • the reflective optical receiver terminal 66a, 66b can be equipped with a grid for eliminating scattered radiation 106 on the receiver terminal tissue contacting surface 70a, 70b.
  • Fig. 10 schematically shows a possible setup of most important components for a NIRS measurement.
  • the device 10 for cerebral measurements is connected by a first optical connection cable 112a with an apparatus 114 for NIRS measurements.
  • the first optical connection cable 112a contains at least three optical fibres, one for transmitting light from the apparatus 114 to the optical connector 17 of the device 10, i.e. to the optical transmitter fibre 15, and two for transmitting light from the optical connector 17, i.e. from the first and the second optical receiver fibres 16a, 16b of the device 10, to the apparatus 114.
  • the device 76 for measurements of hemodynamics of the finger tissue as shown in fig.
  • Said second optical connection cable 112b contains at least two optical fibres, one for transmitting light from the apparatus 114 to the optical connector 17 of device 76, i.e. to the transmitter fibre 15, and one for transmitting light from the optical connector 17 of device 76, i.e. from the first optical receiver fibre 16a, to the apparatus 114.
  • any or more other devices 116 destined for measuring any additional physiological characteristics, is connected with the apparatus 114, preferably by a third optical cable 112c.
  • Said apparatus 114 for NIRS measurements includes light emitting, light detecting, and evaluation means. It is destined for processing optical signals received from the different connected devices by standard and commonly known evaluation processes.
  • the device 10 as depicted e.g. in fig. 1 and 2 is appropriate for measuring hemodynamics and oxygenation of brain tissue. With modifications, as shown in figure 3 and 4 , measurements of hemodynamics and oxygenation of other tissues can be performed, as e.g. shown exemplarily with finger tissue 78. Other modifications of the device 10 or 76, e.g. by omitting the foam layer 58 and the adhesive patch 62a, 62b may allow to measure e.g. invasively hemodynamics and oxygenation of inner organs, like e.g. brain, liver, heart, kidney, bowel, bones, mussles, penis etc.
  • inner organs like e.g. brain, liver, heart, kidney, bowel, bones, mussles, penis etc.
  • a measurement with only a first receiver fibre terminal 38a would be sufficiently since a direct application on an organ of interest can be performed.
  • an interference signal e.g. in the exterior application of the device 10 on the scalp 82, where such an interference signal originating from the scalp 82 and the bone layer 83 has to be compensated, as described above.
  • a measurement with more than one receiver fibre terminal is also feasible in the invasive case, therewith, signals from different depths of the organ of interest can be determined.
  • the device 10 instead of measuring hemodynamics and oxygenation of a specific tissue with the device 10 or an accordingly modified device, it is also possible to use said device for measurements of other physiological parameters of said tissue, as e.g. glucose, excitatoric transmitters (e.g. in the brain), inflammatory mediators (e.g. in transplanted organs), different ions (e.g calcium in the heart) or artificial optical active markers introduced in the body (e.g. associated with tumour labelling) etc.
  • other physiological parameters of said tissue e.g. glucose, excitatoric transmitters (e.g. in the brain), inflammatory mediators (e.g. in transplanted organs), different ions (e.g calcium in the heart) or artificial optical active markers introduced in the body (e.g. associated with tumour labelling) etc.
  • other physiological parameters of said tissue e.g. glucose, excitatoric transmitters (e.g. in the brain), inflammatory mediators (e.g. in transplanted organs), different ions (e.g calcium in the
  • the position of the transmitter cavity 18 and of the first and second receiver cavities 28a, 28b may be permuted, according to the measurement application.
  • the transmitter sleeve through passage portion 54 is formed as a transmitter sleeve slot with its main extension in direction at least approximately perpendicular to the tissue-facing surface 13 destined for allowing a greater manoeuvrability of the optical transmitter fibre 15.
  • the receiver sleeve through passage portions 56a, 56b are formed as a receiver sleeve slots with their main extension in direction at least approximately perpendicular to the tissue-facing surface 13 destined for allowing a greater manoeuvrability of the first and the second optical receiver fibres 16a, 16b.
  • the transmitter sleeve slot and the receiver sleeve slots help avoiding a possible damage of the optical transmitter fibre 15 and the first and the second optical receiver fibres 16a, 16b, respectively, caused by the movements of the reflective optical transmitter terminal 64 and the first and the second reflective optical receiver terminals 66a, 66b, due to their flexible support.
  • a deflection restriction mechanism may be provided destined for restricting the maximum deflection of the reflective optical transmitter terminal 64 within the transmitter housing portion 20 and the maximum deflection of the first and second reflective optical receiver terminals 66a, 66b within the first and second receiver housing portion 30a, 30b.
  • a possible construction of the deflection restriction mechanism is by forming two notches at least approximately perpendicular with respect to the tissue-facing surface 13 of said laminar body 12 on opposite sides of each circular cylindrical body 88a, 88b of said reflective optical transmitter terminal 64 and of said first and second reflective optical receiver terminal 66a, 66b, respectively.
  • the reflective optical transmitter terminal 64 and the first and the second reflective optical receiver terminals 66a, 66b can not be deflected over a predefined, maximum deflection.
  • the planar surface 97a, 97b could also be used as deflection restriction mechanism together with a corresponding counterpart firmly arranged with respect to the laminar body 12, as described above.
  • a helical pressure spring 72 causing the spring force acting on said reflective optical transmitter terminal 64 and on said first and second reflective optical receiver terminals 66a, 66b
  • other spring force like structures can be used, as e.g. a tongue-like spring integrally formed by the laminar body 12.
  • the transmitter cavity 18 and the first and second receiver cavities 28a, 28b are lined on all sides by the transmitter sleeve 50 and the first and second receiver sleeves 52a, 52b, respectively, except on the side of the tissue-facing surface 13 in order to further enhance light shielding properties around the transmitter fibre terminal 24 and the first and second receiver fibre terminals 38a, 38b.
  • the transmitter housing portion 20 and the first and the second receiver housing portions 30a, 30b may be covered on the tissue-facing surface 13 of said laminar body 12 by a transparent membrane or a transparent protection film.
  • the transmitter light shielding bulge 46 and the first and second receiver light shielding bulges 48a, 48b may be injection moulded on the laminar body 12 and be affixed directly on said laminar body 12.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Radiation-Therapy Devices (AREA)

Claims (11)

  1. Dispositif pour le diagnostic et/ou le traitement d'une partie sélectionnée d'un corps par facteur de réflexion optique ou par transmission par fibres optiques, ayant un corps plat (12) comprenant une surface faisant face aux tissus (13), une surface extérieure (14) orientée dans le sens opposé à la surface faisant face aux tissus (13), une ouverture pour émetteur destinée à loger une terminaison de fibre émettrice (24) contenant une fibre optique émettrice (15), et une ouverture pour récepteur destinée à loger un moyen récepteur contenant un moyen récepteur optique ;
    ladite terminaison de fibre émettrice (24) étant conçue pour diriger une lumière entrant à travers ladite fibre optique émettrice (15) vers une direction au moins à peu près perpendiculaire à la surface faisant face aux tissus (13) ;
    ledit moyen récepteur étant conçu pour recueillir la lumière entrant depuis une direction au moins à peu près perpendiculaire à ladite surface faisant face aux tissus (13) dans ledit moyen récepteur optique ;
    des moyens annulaires de protection de l'émetteur contre la lumière pour protéger ladite terminaison de fibre émettrice (24) contre les sources de lumière ambiante ;
    des moyens annulaires de protection du récepteur contre la lumière pour protéger ledit moyen récepteur contre les sources de lumière ambiante ;
    ladite ouverture pour émetteur est une cavité pour émetteur (18) ayant une partie de logement d'émetteur (20) et une partie de passage d'émetteur (22), ladite partie de passage d'émetteur (22) se déchargeant dans ladite partie de logement d'émetteur (20) et permettant le passage à travers elle de ladite fibre optique émettrice (15) ;
    ladite cavité pour émetteur (18) étant formée comme faisant partie intégrante dudit corps plat (12) ;
    ladite ouverture pour récepteur est une cavité pour récepteur (28a, 28b) ayant une partie de logement de récepteur (30a, 30b, respectivement) et une partie de passage de récepteur (34a, 34b, respectivement), ladite partie de passage de récepteur (34a, 34b) se déchargeant dans ladite partie de logement de récepteur (30a, 30b, respectivement) ;
    ladite cavité pour récepteur (28a, 28b) étant formée comme faisant partie intégrante dudit corps plat (12) ;
    ledit moyen annulaire de protection de l'émetteur contre la lumière est formé comme un renflement annulaire de protection de l'émetteur contre la lumière (46) et ledit moyen annulaire de protection du récepteur contre la lumière est formé comme un renflement annulaire de protection du récepteur contre la lumière (48a, 48b) ;
    ledit renflement annulaire de protection de l'émetteur contre la lumière (46) et ledit renflement annulaire de protection du récepteur contre la lumière (48a, 48b) sont disposés fermement par rapport audit corps plat (12), et leurs extrémités libres font saillie par rapport à ladite surface faisant face aux tissus (13) dudit corps plat (12) ;
    un manchon d'émetteur (50) est disposé à l'intérieur de ladite partie de logement de l'émetteur (20), disposé fermement par rapport audit corps plat (12) destiné à protéger ladite terminaison de fibre émettrice (24) contre les sources de lumière ambiante, et un manchon de récepteur (52a, 52b) est disposé à l'intérieur de ladite partie de logement du récepteur (30a, 30b, respectivement), étant disposé fermement par rapport audit corps plat (12) destiné à protéger ledit moyen récepteur contre les sources de lumière ambiante ;
    caractérisé en ce que ledit moyen récepteur est une terminaison de fibre réceptrice (38a, 38b) et ledit moyen récepteur optique est une fibre optique réceptrice (16a, 16b, respectivement) ;
    ladite partie de passage du récepteur (34a, 34b) permettant le passage à travers elle de ladite fibre optique réceptrice (16a, 16b, respectivement) ; et
    ledit manchon de l'émetteur (50) et ledit manchon du récepteur (52a, 52b) sont constitués d'un matériau élastique.
  2. Dispositif selon la revendication 1, caractérisé en ce que ledit manchon de l'émetteur (50) s'étend au-dessus d'au moins à peu près la profondeur totale de ladite partie de logement de l'émetteur (20) dans une direction au moins à peu près perpendiculaire à ladite surface faisant face aux tissus (13), ayant une partie de passage (54) à travers le manchon de l'émetteur permettant le passage à travers elle de ladite fibre optique émettrice (15).
  3. Dispositif selon la revendication 2, caractérisé en ce que ledit manchon du récepteur (52a, 52b) s'étend au-dessus d'au moins à peu près la profondeur totale de ladite partie de logement du récepteur (30a, 30b, respectivement) dans une direction au moins à peu près perpendiculaire à ladite surface faisant face aux tissus (13), ayant une partie de passage (56a, 56b, respectivement) à travers le manchon du récepteur permettant le passage à travers elle de ladite fibre optique réceptrice (16a, 16b, respectivement).
  4. Dispositif selon l'une quelconque des revendications 1 à 3, caractérisé en ce que ledit renflement annulaire de protection de l'émetteur contre la lumière (46) est formé comme faisant partie intégrante par ledit manchon de l'émetteur (50) et ledit renflement annulaire de protection du récepteur contre la lumière (48a, 48b) est formé comme formant partie intégrante par ledit manchon du récepteur (52a, 52b, respectivement).
  5. Dispositif selon l'une quelconque des revendications précédentes, caractérisé en ce que ladite terminaison de la fibre émettrice (24) a une terminaison réfléchissante d'émetteur optique (64) étant disposée dans ladite partie de logement de l'émetteur (20) et étant en contact avec ladite fibre optique émettrice (15), et ladite terminaison de la fibre réceptrice (38a, 38b) a une terminaison réfléchissante de récepteur optique (66a, 66b, respectivement) étant disposée dans ladite partie de logement du récepteur (30a, 30b, respectivement) et étant en contact avec ladite fibre optique réceptrice (16a, 16b, respectivement).
  6. Dispositif selon la revendication 5, caractérisé en ce que ladite terminaison réfléchissante de l'émetteur optique (64) est supportée de manière flexible à l'intérieur de ladite partie de logement de l'émetteur (20) par rapport à des flexions au moins à peu près perpendiculaires à ladite surface faisant face aux tissus (13) et ladite terminaison réfléchissante du récepteur optique (66a, 66b) est supportée de manière flexible à l'intérieur de ladite partie de logement du récepteur (30a, 30b, respectivement) par rapport à des flexions au moins à peu près perpendiculaires à ladite surface faisant face aux tissus (13).
  7. Dispositif selon la revendication 6, caractérisé en ce qu'une force de ressort dans une direction au moins à peu près perpendiculaire à ladite surface faisant face aux tissus (13) agit sur ladite terminaison réfléchissante de la fibre optique émettrice (64) et sur ladite terminaison réfléchissante de la fibre optique réceptrice (66a, 66b), ce qui a pour effet que ladite terminaison réfléchissante de la fibre optique émettrice (64) fait légèrement saillie ou est au moins à peu près sur un même plan par rapport à l'extrémité libre dudit renflement annulaire de protection de l'émetteur contre la lumière (46) et ladite terminaison réfléchissante de la fibre optique réceptrice (66a, 66b) fait légèrement saillie ou est au moins à peu près sur le même plan par rapport à l'extrémité libre dudit renflement annulaire de protection du récepteur contre la lumière (48a, 48b, respectivement).
  8. Dispositif selon la revendication 7, caractérisé en ce que ladite force de ressort est causée par un ressort hélicoïdal de pression (72a, 72b, 72c) disposé fermement avec ledit corps plat (12) ou par un ressort ayant la forme d'une langue formé comme faisant partie intégrante dudit corps plat (12).
  9. Dispositif selon l'une quelconque des revendications précédentes, caractérisé en ce que ledit corps plat (12) est couvert par une couche de mousse (58), de préférence avec des propriétés d'absorption de la lumière, disposée fermement sur ladite surface faisant face aux tissus (13).
  10. Dispositif selon la revendication 9 et la revendication 7 ou 8, comme quoi l'extrémité libre dudit renflement annulaire de protection de l'émetteur contre la lumière (46) et l'extrémité libre dudit renflement annulaire de protection du récepteur contre la lumière (48a, 48b) font saillie ou sont au moins à peu près sur le même plan par rapport à la surface exposée de ladite couche de mousse (58).
  11. Dispositif selon l'une quelconque des revendications précédentes, caractérisé en ce qu'une pièce adhésive (62a, 62b) est fermement disposée sur ladite surface extérieure (14) dudit corps plat (12).
EP08016828A 2008-09-25 2008-09-25 Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique Active EP2168475B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08016828A EP2168475B1 (fr) 2008-09-25 2008-09-25 Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique
AT08016828T ATE547980T1 (de) 2008-09-25 2008-09-25 Vorrichtung zur diagnose und/oder therapie physiologischer eigenschaften eines ausgewählten körperteils durch optische reflexion oder transmission
US13/119,325 US8909313B2 (en) 2008-09-25 2009-09-04 Device for diagnosis and/or therapy of physiological characteristics of a selected portion of a body by optical reflectance or optical transmission
PCT/EP2009/006410 WO2010034398A1 (fr) 2008-09-25 2009-09-04 Dispositif permettant le diagnostic et/ou le traitement de caractéristiques physiologiques d’une partie sélectionnée d’un corps par réflectance optique ou par transmission optique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08016828A EP2168475B1 (fr) 2008-09-25 2008-09-25 Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique

Publications (2)

Publication Number Publication Date
EP2168475A1 EP2168475A1 (fr) 2010-03-31
EP2168475B1 true EP2168475B1 (fr) 2012-03-07

Family

ID=40638154

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08016828A Active EP2168475B1 (fr) 2008-09-25 2008-09-25 Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique

Country Status (4)

Country Link
US (1) US8909313B2 (fr)
EP (1) EP2168475B1 (fr)
AT (1) ATE547980T1 (fr)
WO (1) WO2010034398A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10064554B2 (en) * 2011-12-14 2018-09-04 The Trustees Of The University Of Pennsylvania Fiber optic flow and oxygenation monitoring using diffuse correlation and reflectance
WO2014051685A1 (fr) * 2012-09-27 2014-04-03 Ivwatch, Llc Appareil et méthode servant à atténuer le bruit affectant un signal transcutané
WO2021263207A1 (fr) 2020-06-26 2021-12-30 Caliber Imaging & Diagnostics, Inc. Système pour permettre un accès à distance et rapide à des données d'image numérisées

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281645A (en) 1977-06-28 1981-08-04 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs
US5217013A (en) 1983-10-14 1993-06-08 Somanetics Corporation Patient sensor for optical cerebral oximeter and the like
WO1992021281A1 (fr) 1991-05-31 1992-12-10 Susi Roger E Appareil indiquant les parametres d'un patient subissant un examen par visualisation a resonnance magnetique nucleaire
WO1994012096A1 (fr) * 1992-12-01 1994-06-09 Somanetics Corporation Capteur pour oxymetres optiques cerebraux destine a un patient
JPH09501074A (ja) * 1993-05-20 1997-02-04 ソマネテイツクス コーポレイシヨン 分光測光医療器用の改良電子光学センサー
US6041247A (en) * 1995-11-29 2000-03-21 Instrumentarium Corp Non-invasive optical measuring sensor and measuring method
US5937860A (en) * 1997-04-10 1999-08-17 Cook; Daniel J. Laryngeal mask
IT1302018B1 (it) 1998-08-11 2000-07-20 Ausimont Spa Agenti espandenti.
US7047054B2 (en) 1999-03-12 2006-05-16 Cas Medical Systems, Inc. Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
US6343177B1 (en) 1999-03-26 2002-01-29 Datex-Ohmeda, Inc. Over-molded reflective optical fiber terminal
ATE297685T1 (de) 2000-07-21 2005-07-15 Univ Zuerich Sonde und vorichtung zur messung zerebraler hämodynamik und sauerstoffsättigung
US6606509B2 (en) 2001-03-16 2003-08-12 Nellcor Puritan Bennett Incorporated Method and apparatus for improving the accuracy of noninvasive hematocrit measurements
AU2003254135B2 (en) 2002-07-26 2006-11-16 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
JP4489385B2 (ja) * 2002-12-12 2010-06-23 株式会社日立メディコ 計測プローブ及び生体光計測装置
US7613489B2 (en) 2004-05-18 2009-11-03 Hutchinson Technology Incorporated Optimized wavelength gap for improved StO2 measurement
US7899510B2 (en) * 2005-09-29 2011-03-01 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8190229B2 (en) * 2005-09-29 2012-05-29 Conmed Corporation Sensor holder
US8195264B2 (en) 2006-09-22 2012-06-05 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same

Also Published As

Publication number Publication date
US20110196241A1 (en) 2011-08-11
WO2010034398A1 (fr) 2010-04-01
ATE547980T1 (de) 2012-03-15
EP2168475A1 (fr) 2010-03-31
US8909313B2 (en) 2014-12-09

Similar Documents

Publication Publication Date Title
US4510938A (en) Body-mounted light source-detector apparatus
US6487343B1 (en) Fiber optic light mixer
US6253097B1 (en) Noninvasive medical monitoring instrument using surface emitting laser devices
US8428674B2 (en) Apparatus for spectrometric based oximetry
JPS59141932A (ja) 代謝監視装置
US5584296A (en) Patient sensor for optical cerebral oximeters and the like
US7096052B2 (en) Optical probe including predetermined emission wavelength based on patient type
US8948849B2 (en) System and method for optode and electrode positioning cap for electroencephalography, diffuse optical imaging, and functional neuroimaging
US7706853B2 (en) Near infrared spectroscopy device with reusable portion
US6892006B2 (en) Fiber optic light mixer
EP0745348B1 (fr) Connecteur de sonde muni de capteur de diode à laser
US20090108205A1 (en) Nirs sensor mounting apparatus
CN101257839A (zh) 医用传感器及其使用技术
CN103200865A (zh) 用于连续无创动脉血压监测的用后可弃和可拆卸传感器
WO1998005252A1 (fr) Sphygo-oxymetre neonatal ou pour nourrissons
US20140073899A1 (en) Photoacoustic sensor system
US20060161055A1 (en) Probe design
US20100317949A1 (en) Optical coupler for non-invasive spectrophotometric patient monitoring
EP2168475B1 (fr) Dispositif pour le diagnostic et/ou la thérapie des caractéristiques physiologiques d'une partie choisie d'un corps par réflectance optique ou transmission optique
JP2002355246A (ja) 生体光計測用装着具および生体光計測装置
WO2012051617A2 (fr) Système et procédé de casque de positionnement d'optodes et d'électrodes pour l'électroencéphalographie, l'imagerie optique diffuse, et la neuroimagerie fonctionnelle
CN115153532B (zh) 一种头戴式柔性光纤组件
JP2004313741A (ja) 光生体測定装置及びホルダー
WO2024038319A1 (fr) Dispositif portable
CN117396129A (zh) 探测单元

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

17P Request for examination filed

Effective date: 20100724

17Q First examination report despatched

Effective date: 20100825

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 547980

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120315

Ref country code: CH

Ref legal event code: EP

Ref country code: CH

Ref legal event code: NV

Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602008013861

Country of ref document: DE

Effective date: 20120503

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120607

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120608

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 547980

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120707

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120709

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

26N No opposition filed

Effective date: 20121210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602008013861

Country of ref document: DE

Effective date: 20121210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120930

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120618

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120607

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120307

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120925

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080925

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230425

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20231001

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240918

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240919

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240925

Year of fee payment: 17